Motherisk rounds. Warfarin embryopathy following low-dose maternal exposure

J Obstet Gynaecol Can. 2005 Jul;27(7):702-6. doi: 10.1016/s1701-2163(16)30550-3.

Authors

Yaron Finkelstein¹, David Chitayat, Tal Schechter, Sarah Keating, Ants Toi, Gideon Koren

Affiliation

¹ Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, ON.

PMID: 16100627
DOI: 10.1016/s1701-2163(16)30550-3

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Abnormalities, Drug-Induced* / embryology
Abnormalities, Drug-Induced* / epidemiology
Adult
Anticoagulants / adverse effects*
Anticoagulants / therapeutic use
Female
Humans
Infant, Newborn
Maternal Exposure
Pregnancy
Prenatal Exposure Delayed Effects*
Warfarin / adverse effects*
Warfarin / therapeutic use

Substances

Anticoagulants
Warfarin